Protocol for Using CRISPR-Cas9 to Generate a Monocyte Cell Line Harboring a Single-Nucleotide Polymorphism
BIO-PROTOCOL · 2026 · 16 (1395)
DOI: 10.21769/bioprotoc.5660 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift BIO-PROTOCOL, 2026. Verfasst von Amar Chandra Mahatha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Allergy and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO,…. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
We established a step-by-step approach for generating a single-nucleotide mutation in the promoter region of an immune regulatory gene in human monocyte THP-1 cells by employing a plasmid-based CRISPR-Cas9 system delivered via transfection with a homology-directed repair template DNA (HDR). Key steps include designing a single-guide RNA (sgRNA), cloning it into a CRISPR plasmid encoding the Cas9 protein, transfection of the plasmid constructs along with single-stranded oligonucleotide repair template (ssODNs) into THP-1 cells, followed by selection and validation. This approach provides a precise and relevant model to investigate the role of single polymorphisms in the regulation of inflammatory gene expression in human monocytes. In addition to the rs1024611 single-nucleotide polymorphism (SNP), this CRISPR/Cas9-based strategy is broadly applicable to functional studies of noncoding and coding variants in innate immune genes. Key features • Precise genome editing: CRISPR-Cas9-mediated editing of the rs1024611 SNP in the endogenous CCL2 promoter in THP-1 cells using a single-stranded donor oligonucleotide. • Generate THP-1 monocytic cell lines: Differing only at the rs1024611 locus, allowing precise comparison of allele-specific effects on the same genetic background. • The protocol includes strategies for single-cell cloning, PCR-based genotyping, and Sanger sequencing to confirm precise genome editing. • While this study focuses on the CCL2-2518 SNP, it provides a framework for future investigations of other noncoding variants or regulatory SNPs in immune-related genes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Allergy and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO, USA.
- College of Arts and Sciences; Saint Louis University, Saint Louis, MO, USA.
- Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Saint Louis, MO, USA.
Zitieren
APA
Mahatha, A. C., Ramos-Espinosa, O., de Lima, D. S., Liu, E. Y., Vaidyan, S., & Liu, J. (2026). Protocol for Using CRISPR-Cas9 to Generate a Monocyte Cell Line Harboring a Single-Nucleotide Polymorphism. BIO-PROTOCOL, 16(1395). https://doi.org/10.21769/bioprotoc.5660
Vancouver
Mahatha AC, Ramos-Espinosa O, de Lima DS, Liu EY, Vaidyan S, Liu J. Protocol for Using CRISPR-Cas9 to Generate a Monocyte Cell Line Harboring a Single-Nucleotide Polymorphism. BIO-PROTOCOL. 2026;16(1395). doi:10.21769/bioprotoc.5660
BibTeX
@article{Mahatha2026,
author = {Mahatha, Amar Chandra and Ramos-Espinosa, Octavio and de Lima, Dhemerson Souza and Liu, Ethan Y and Vaidyan, Sarah and Liu, Jianguo},
title = {Protocol for Using CRISPR-Cas9 to Generate a Monocyte Cell Line Harboring a Single-Nucleotide Polymorphism},
journal = {BIO-PROTOCOL},
year = {2026},
volume = {16},
number = {1395},
doi = {10.21769/bioprotoc.5660}
}
EUVIMED